Luc Paquet

Luc Paquet is an experienced executive in the biotech and pharmaceutical sectors, currently serving as Chief Executive Officer and Chief Corporate Development Officer at Immune Biosolutions inc. since May 2021. Paquet also operates a consulting firm, Consultation Luc Paquet, since August 2018, and previously held the position of President and CEO at Univalor from July 2019 to March 2021. Prior roles include President and General Director at Transfertech Sherbrooke, and various leadership positions at CQDM, Université de Sherbrooke, Topigen Pharmaceutiques Inc., and Aegera Therapeutics Inc. Paquet holds a Ph.D. in Biomedical Sciences from Université de Montréal and a B.Sc. in Biochemistry from Université de Sherbrooke.